33 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... Antifungal Treatment ... Antifungal Treatment ... Antifungal Treatment ... Meningoencephalitis #IDSA
Junctional Rhythms - Junctional rhythm describes an abnormal heart rhythm resulting from impulses coming from a
junction" between atria ... Cardiology #MedStudent #EKG ... RetrogradeP #Escape #ECGEducator
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
Wolff-Parkinson-White Syndrome

WPW is a congenital abnormality characterized by an abnormal accessory conduction pathway between the atria
pathway between the atria ... QRS interval on EKG ... The definitive treatment ... WPW #Cardiology #ECG ... #EKG #Electrocardiogram
Wolff–Parkinson–White syndrome (WPW) is one of several disorders of the electrical system of the heart that
pathway between the atria ... Cardiology #MedStudent #EKG ... ShortPR #Criteria #ECGEducator
Wernicke Encephalopathy - Acute B1 (Thiamine) Deficiency - Diagnosis and Management
Diagnosis - Caine Criteria (2 of
dysfunctions ( e.g ... Cerebellar dysfunction (e.g ... . gait ataxia - ... Anorexia nervosa Treatment ... Encephalopathy • A prompt treatment
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
and Management - IDSA ... Echinocandins (e.g ... #Candidemia #IDSA ... #candidiasis #treatment
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... dose of 20–60 mg/kg ... ., 4 mg/kg on days ... Leishmaniasis #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... duration same as for treatment ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #Prevention #Treatment